Suscribirse

Early Invasive Versus Initial Conservative Strategies for Women with Non–ST-Elevation Acute Coronary Syndromes: A Nationwide Analysis - 23/08/17

Doi : 10.1016/j.amjmed.2017.01.049 
Islam Y. Elgendy, MD a, , Ahmed N. Mahmoud, MD a, Hend Mansoor, PharmD, MS b, Anthony A. Bavry, MD, MPH a, c
a Department of Medicine, University of Florida, Gainesville 
b Department of Pharmaceutical Outcomes and Policy, University of Florida, Gainesville 
c North Florida/South Georgia Veterans Health System, Gainesville, Fla 

Requests for reprints should be addressed to Islam Y. Elgendy, MD, Department of Medicine, Division of Cardiovascular Medicine, University of Florida, 1600 SW Archer Rd, Gainesville, FL 32610.Department of MedicineDivision of Cardiovascular MedicineUniversity of Florida1600 SW Archer RdGainesvilleFL32610

Abstract

Background

Studies conducted largely in men have shown improved outcomes with an early invasive strategy with non–ST-elevation acute coronary syndrome. In contrast, data have been less conclusive in women, with some trials demonstrating potential harm. This study aims to assess whether an early invasive strategy in women is associated with better outcomes in real-world data.

Methods

Women admitted with a primary diagnosis of non–ST-elevation myocardial infarction or unstable angina were identified from the National Inpatient Sample years 2012 and 2013. The incidence of in-hospital mortality in women with non–ST-elevation acute coronary syndrome undergoing an early invasive strategy versus an initial conservative strategy was compared using a propensity score–matched analysis.

Results

Among 372,080 women with non–ST-elevation acute coronary syndrome, 153,680 (41.3%) were managed with an early invasive strategy and 218,400 (58.7%) were managed with an initial conservative strategy. Propensity score–matched 19,965 women were treated with an early invasive strategy, and 20,009 women were treated with an initial conservative strategy. The risk of in-hospital mortality was lower with an early invasive strategy (2.1% vs 3.8%; odds ratio [OR], 0.55; 95% confidence interval [CI], 0.49-0.62). This benefit was noted in women presenting with non–ST-segment elevation myocardial infarction (OR, 0.52; 95% CI, 0.46-0.58) and was not observed in women with unstable angina (OR, 5.14; 95% CI, 0.47-56.9), Pinteraction = .06. A propensity-adjusted analysis yielded similar results (OR, 0.51; 95% CI, 0.45-0.57).

Conclusions

In this large contemporary observational analysis of women with non–ST-elevation acute coronary syndrome, an early invasive strategy was associated with lower in-hospital mortality. This benefit was observed in women presenting with non–ST-elevation myocardial infarction but not with unstable angina. These findings provide evidence supporting the guideline recommendations for an early invasive strategy in women with non–ST-elevation acute coronary syndrome and high-risk features (eg, troponin positive).

El texto completo de este artículo está disponible en PDF.

Keywords : Acute coronary syndrome, Mortality, Propensity score, Women


Esquema


 Funding: None.
 Conflict of Interest: AAB declares honorarium from the American College of Cardiology.
 Authorship: All authors had access to the data and played a role in writing this manuscript.
 IYE and ANM equally contributed to this article.


© 2017  Elsevier Inc. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 130 - N° 9

P. 1059-1067 - septembre 2017 Regresar al número
Artículo precedente Artículo precedente
  • Hiccups as Herald: Neuromyelitis Optica Spectrum Disorder
  • Akshjot Puri, Michael Chesser, Keith Chan, Viswanatha Kharidi
| Artículo siguiente Artículo siguiente
  • Post-Discharge Worsening Renal Function in Patients with Type 2 Diabetes and Recent Acute Coronary Syndrome
  • Nuccia Morici, Stefano Savonitto, Claudio Ponticelli, Ilse C. Schrieks, Anna Nozza, Francesco Cosentino, Barbara E. Stähli, Pasquale Perrone Filardi, Gregory G. Schwartz, Linda Mellbin, A. Michael Lincoff, Jean-Claude Tardif, Diederick E. Grobbee

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.